Profiel
Kamil Kopec has worked as a Chief Operating Officer at NanoSanguis SA since 2016 and currently holds the position.
He also currently works as a Chief Operating Officer at NanoThea SA.
Actieve functies van Kamil Kopec
| Bedrijven | Functie | Begin |
|---|---|---|
NanoSanguis SA
 NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland. | Operationeel Directeur | 01-02-2016 |
NanoThea SA
 NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
NanoSanguis SA
NanoSanguis SA Medical SpecialtiesHealth Technology NanoSanguis SA develops red blood cells substitutes which can alternate to natural blood. The company was founded by Agata Stefanek and Tomasz Ciach in December 2015 and is headquartered in Warsaw, Poland. | Health Technology |
NanoThea SA
NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland. | Health Technology |
